| Literature DB >> 35645479 |
Jaikiran Kaur1, Prathima Gajula Shivashankarappa1, A Sanguida1, M Suganya1, G Ezhumalai2.
Abstract
Aim and objective: To assess the effectiveness of visual distraction with and without virtual reality glasses in reducing dental anxiety among children with hearing and speech disabilities undergoing dental treatment. Materials and methods: Twenty-four children with hearing and speech disabilities aged 6-12 years were selected and were randomly divided into three groups (N = 8). Children in group A received no distraction, group B received visual distraction using virtual reality (VR) glasses and group C received visual distraction without VR glasses during dental treatment. The anxiety levels were measured using PJS- Pictorial Scale and physiological parameters - before, during, and after a dental procedure. Then intragroup and intergroup comparison was done.Entities:
Keywords: Behavior management; Dental anxiety; Distraction; Hearing impairment; Virtual reality
Year: 2021 PMID: 35645479 PMCID: PMC9108807 DOI: 10.5005/jp-journals-10005-2100
Source DB: PubMed Journal: Int J Clin Pediatr Dent ISSN: 0974-7052
Fig. 1Oral prophylaxis without any distraction
Fig. 2Oral prophylaxis with visual distraction using VR glasses
Fig. 3Oral prophylaxis with visual distraction without VR glasses
Fig. 4Customized animation video on oral health education for hearing and speech impaired children in English
Fig. 5Customized animation video on oral health education for hearing and speech impaired children in regional language
Descriptive statistics and intragroup comparison of anxiety scores (PJS-PS) in groups A, B, and C
|
| |||||
|---|---|---|---|---|---|
|
|
|
|
|
|
|
| A | 3.38 ± 0.518 | 3.50 ± 1.31 | 1.88 ± 1.13 | 9.852 | 0.007a |
| B | 3.00 ± 0.76 | 2.25 ± 0.89 | 1.13 ± 0.35 | 13.556 | 0.001a |
| C | 3.25 ± 0.71 | 2.88 ± 0.64 | 2.38 ± 0.92 | 3.769 | 0.152 |
SD, standard deviation; χ2, Chi-square test; astatistical significance (p < 0.05) using Friedman test
Post-hoc test for comparison of PJS-PS score at baseline, during treatment and after treatment for groups A, B and C
|
|
|
| |
|---|---|---|---|
|
|
|
| |
| Baseline vs During treatment | -0.12 (0.739) | 0.75 (0.034)a | 0.37 (0.180) |
| During vs After treatment | 1.62 (0.017)a | 1.12 (0.024)a | 0.50 (0.340) |
| Baseline vs After treatment | 1.50 (0.024)a | 1.87 (0.011)a | 0.87 (0.068) |
aStatistical significance (p-value < 0.05) using Wilcoxon signed-rank test
Pairwise intergroup comparison of anxiety scores values at during- and after-treatment
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|
| During treatment anxiety score | A | 8 | 11.00 | 88.00 | 12.0 | -2.162 | 0.031a |
| B | 8 | 6.00 | 48.00 | ||||
| After treatment anxiety score | A | 8 | 10.13 | 81.00 | 19.0 | -1.667 | 0.095 |
| B | 8 | 6.88 | 55.00 | ||||
| During treatment anxiety score | B | 8 | 7.00 | 56.00 | 20.0 | -1.403 | 0.161 |
| C | 8 | 10.00 | 80.00 | ||||
| After treatment anxiety score | B | 8 | 5.31 | 42.50 | 6.5 | -2.912 | 0.004a |
| C | 8 | 11.69 | 93.50 | ||||
| During treatment anxiety score | A | 8 | 10.31 | 82.50 | 17.5 | -1.594 | 0.111 |
| C | 8 | 6.69 | 53.50 | ||||
| After treatment anxiety score | A | 8 | 7.19 | 57.50 | 21.5 | -1.155 | 0.248 |
| C | 8 | 9.81 | 78.50 |
N, number of subjects; Z, overall rank mean; astatistical significance (p-value < 0.05) using Mann-Whitney test